CytomX Therapeutics to Report Second Quarter 2025 Financial Results on August 7, 2025

Group 1 - CytomX Therapeutics, Inc. will report its second quarter financial results on August 7, 2025, after U.S. market close [1] - A conference call and webcast will follow the financial results announcement at 5:00 p.m. ET / 2:00 p.m. PT [1][2] - Participants can access the live webcast from CytomX's website and are advised to register at least 10 minutes prior to the call [2] Group 2 - CytomX is a clinical-stage biopharmaceutical company focused on developing conditionally activated biologics for cancer treatment [3] - The company's pipeline includes therapeutic candidates such as CX-2051, a masked ADC targeting EpCAM, and CX-801, a masked interferon alpha-2b PROBODY cytokine [3] - CytomX has established collaborations with major oncology leaders including Amgen, Astellas, and Bristol Myers Squibb [3]